enocitabine has been researched along with Leukemia P388 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirano, S; Iguchi, H; Izumi, H; Matsushita, Y; Takeuchi, T; Tone, H | 1 |
| Kiyota, T; Kuriyama, H; Watanabe, A | 1 |
| Higashigawa, M; Hori, H; Kamiya, H; Kawasaki, H; Nobori, T; Ochiai, H; Ohkubo, T; Sakurai, M | 1 |
3 other study(ies) available for enocitabine and Leukemia P388
| Article | Year |
|---|---|
Experimental combination chemotherapy of pirarubicin with various antitumor drugs against P388 murine leukemia.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Screening Assays, Antitumor; Fluorouracil; Leukemia P388; Male; Mercaptopurine; Methotrexate; Mice; Mice, Inbred BALB C; Mitomycin; Peplomycin; Vindesine | 1994 |
[Antitumor effects of Behenoyl-ara-C (BH-AC) in combination with Idarubicin (IDA) in P 388 leukemic cell bearing mice].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Screening Assays, Antitumor; Female; Idarubicin; Leukemia P388; Mice; Neoplasm Transplantation; Tumor Cells, Cultured | 1996 |
Intracellular pharmacokinetics of N4-behenoyl-1-beta-D-arabinofuranosylcytosine.
Topics: Animals; Antineoplastic Agents; Chromatography, High Pressure Liquid; Cytarabine; DNA; Leukemia P388; Leukemia, Experimental; Mice; Tumor Cells, Cultured | 1989 |